Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Experimental System Myovoice

Research Leaders

6 sponsors active, led by Fondazione Don Carlo Gnocchi ETS

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07562100Not ApplicableRecruiting

Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer

NCT06546813RecruitingPrimary

Outcomes of ICT Assistive Technology in RehabiliTAtIoN Pathways

NCT04762043Not ApplicableCompleted

MyoVoice to Restore Natural, Hands-free Communication to Individuals With Vocal Impairments

Showing all 3 trials

Research Network

Common Treatments

  • Experimental System Myovoice1
  • Prehabilitation Application1
  • Aibased Physiotherapy1
  • Scales And Questionnaire Administration1
  • Scar Management1

Active Sponsors

  • Fondazione Don Carlo Gnocchi ETS1
  • Altec Inc.1
  • National Yang Ming Chiao Tung University Hospital1
  • Ministry of Health, Italy1
  • National Taiwan University Hospital1

Top Investigators

Related Conditions

  • Speech Intelligibility1
  • Speech Perception1
  • Rehabilitation1
  • Quality Of Life1
  • Motor Function1

Activity Timeline